Impairment of human dopaminergic neurons at different developmental stages by perfluoro-octanoic acid (PFOA) and differential human brain areas accumulation of perfluoroalkyl chemicals.

Central Nervous System Dopamine Transporter Dopaminergic neuron Human Induced Pluripotent stem (h-iPS) cells Perfluoroalkyl substances Tyrosine Hydroxylase

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2022
Historique:
received: 26 08 2021
revised: 09 11 2021
accepted: 10 11 2021
pubmed: 16 11 2021
medline: 8 1 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

Perfluoroalkyl substances (PFASs) are synthetic chemicals widely used in industrial and consumer products. The environmental spreading of PFASs raises concerns for their impact on human health. In particular, the bioaccumulation in humans due to environmental exposure has been reported also in total brain samples and PFAS exposure has been associated with neurodevelopmental disorders. In this study we aimed to investigate the specific PFAS bioaccumulation in different brain areas. Our data reported major accumulation in the brainstem region, which is richly populated by dopaminergic neurons (DNs), in brain autopsy samples from people resident in a PFAS-polluted area of Italy. Since DNs are the main source of dopamine (DA) in the mammalian central nervous system (CNS), we evaluated the possible functional consequences of perfluoro-octanoic acid (PFOA) exposure in a human model of DNs obtained by differentiation of human induced pluripotent stem cells (hiPSCs). Particularly, we analyzed the specific effect of the exposure to PFOA for 24 h, at the concentration of 10 ng/ml, at 3 different steps of dopaminergic differentiation: the neuronal commitment phase (DP1), the neuronal precursor phase (DP2) and the mature dopaminergic differentiation phase (DP3). Interestingly, compared to untreated cells, exposure to PFOA was associated with a reduced expression of Tyrosine Hydroxylase (TH) and Neurofilament Heavy (NFH), both markers of dopaminergic maturation at DP2 phase. In addition, cells at DP3 phase exposed to PFOA showed a severe reduction in the expression of the Dopamine Transporter (DAT), functionally involved in pre-synaptic dopamine reuptake. In this proof-of-concept study we show a significant impact of PFOA exposure, mainly on the most sensitive stage of neural dopaminergic differentiation, prompting the way for further investigations more directly relevant to risk assessment of these chemicals.

Identifiants

pubmed: 34781208
pii: S0160-4120(21)00607-3
doi: 10.1016/j.envint.2021.106982
pii:
doi:

Substances chimiques

Alkanesulfonic Acids 0
Caprylates 0
Fluorocarbons 0
octanoic acid OBL58JN025

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106982

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Andrea Di Nisio (A)

Department of Medicine, University of Padova, Padova, Italy.

Micaela Pannella (M)

Department of Medicine, University of Padova, Padova, Italy.

Stefania Vogiatzis (S)

Venetian Institute of Molecular Medicine - VIMM, Department of Physics and Astronomy, University of Padova, Italy.

Stefania Sut (S)

Department of Medicine, University of Padova, Padova, Italy.

Stefano Dall'Acqua (S)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Maria Santa Rocca (MS)

Department of Medicine, University of Padova, Padova, Italy.

Angelo Antonini (A)

Department of Neuroscience, University of Padua, Padova, Italy.

Andrea Porzionato (A)

Department of Neuroscience, University of Padua, Padova, Italy.

Raffaele De Caro (R)

Department of Neuroscience, University of Padua, Padova, Italy.

Mario Bortolozzi (M)

Venetian Institute of Molecular Medicine - VIMM, Department of Physics and Astronomy, University of Padova, Italy.

Luca De Toni (L)

Department of Medicine, University of Padova, Padova, Italy. Electronic address: luca.detoni@unipd.it.

Carlo Foresta (C)

Department of Medicine, University of Padova, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH